Court of Justice 31 March 2011, C-427/09 (Generics (UK) Ltd v Synaptech Inc.)
Also known as
European Union · · · 31-03-2011
Opinion of the Advocate-General Opinion of the Advocate-General 1. Under the Community harmonising legislation concerning medicinal products, such products may be placed on the market only on completion of a lengthy authorisation procedure, which was introduced in order to protect public health.
Read the full text
This document is published by eur-lex.europa.eu.
Moonlit adds the citation network, article-level links and cross-references, which are available to search for free.
Sign in to Moonlit